Peter Jianrui Liu
CEO
Oxford Cancer Analytics (OXcan)
Peter Liu is a physician, scientist, and Forbes recognized entrepreneur with 13+ years of experience in oncology&innovation. As CEO of Oxford Cancer Analytics, he is pioneering a new generation of blood tests for early cancer detection, to enable curative treatments. His innovation experiences span 4 continents, working at the WHO, leading the Oxford University Scientific Society as President, and founding an international innovation think tank. He holds a MD from UToronto and a PhD from Oxford.
Schedule
25 mins
St. Lawrence Centre for the Arts - Jane Mallett Theatre
Guardians of the Cure: Putting Patients First in the Science of Drug Development
Drug development is a complex journey, with 90% of drugs failing to reach the market even after extensive research and clinical trials. This discussion highlights the pivotal role of drug formulation, and how technology, data, and AI are revolutionizing personalized medicine. Using real-world success stories with global impact, this conversation sheds light on how advancements are reshaping healthcare and why active involvement from developers to patients is key in shaping its future.
